Garcia JA - Search Results

1

Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial.

Bryce AH, Chen YH, Liu G, Carducci MA, Jarrard DM, Garcia JA, Dreicer R, Hussain M, Eisenberger MA, Plimack ER, Vogelzang NJ, DiPaola RS, Harshman L, Sweeney CJ. Bryce AH, et al. Among authors: garcia ja. Eur Urol Oncol. 2020 Dec;3(6):717-724. doi: 10.1016/j.euo.2020.07.001. Epub 2020 Aug 15. Eur Urol Oncol. 2020. PMID: 32807727 Free PMC article. Clinical Trial.

2

Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.

Garcia JA, Dreicer R. Garcia JA, et al. Nat Clin Pract Urol. 2005 Jan;2(1):32-7. doi: 10.1038/ncpuro0068. Nat Clin Pract Urol. 2005. PMID: 16474574 Review.

3

Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics.

Thakkar SG, Choueiri TK, Garcia JA. Thakkar SG, et al. Among authors: garcia ja. Curr Oncol Rep. 2006 Mar;8(2):108-13. doi: 10.1007/s11912-006-0045-1. Curr Oncol Rep. 2006. PMID: 16507220

4

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: garcia ja. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

5

Systemic chemotherapy for advanced bladder cancer: update and controversies.

Garcia JA, Dreicer R. Garcia JA, et al. J Clin Oncol. 2006 Dec 10;24(35):5545-51. doi: 10.1200/JCO.2006.08.0564. J Clin Oncol. 2006. PMID: 17158540 Review.

6

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM. Rini BI, et al. J Natl Cancer Inst. 2007 Jan 3;99(1):81-3. doi: 10.1093/jnci/djk008. J Natl Cancer Inst. 2007. PMID: 17202116

7

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.

Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI. Tamaskar I, et al. Ann Oncol. 2008 Feb;19(2):265-8. doi: 10.1093/annonc/mdm483. Epub 2007 Oct 24. Ann Oncol. 2008. PMID: 17962201 Free article.

8

Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.

Tamaskar I, Garcia JA, Elson P, Wood L, Mekhail T, Dreicer R, Rini BI, Bukowski RM. Tamaskar I, et al. Among authors: garcia ja. J Urol. 2008 Jan;179(1):81-6; discussion 86. doi: 10.1016/j.juro.2007.08.127. Epub 2007 Nov 12. J Urol. 2008. PMID: 17997441

9

Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.

Garcia JA, Klein EA, Magi-Galluzzi C, Elson P, Triozzi P, Dreicer R. Garcia JA, et al. Clin Cancer Res. 2008 May 15;14(10):3052-9. doi: 10.1158/1078-0432.CCR-07-4731. Clin Cancer Res. 2008. PMID: 18483371 Clinical Trial.

10

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.

Rini BI, Choueiri TK, Elson P, Khasawneh MK, Cotta C, Unnithan J, Wood L, Mekhail T, Garcia J, Dreicer R, Bukowski RM. Rini BI, et al. Cancer. 2008 Sep 15;113(6):1309-14. doi: 10.1002/cncr.23711. Cancer. 2008. PMID: 18618496 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,138 results

Search Page

Filters